Scope
The IAP practice chapter combines clinical diagnosis, adequate analgesia and selective antibiotic prescribing for childhood acute otitis media. Age, symptom severity, laterality and follow-up reliability determine whether initial observation is suitable; non-response requires reassessment.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Confirm middle-ear inflammation and effusion
- Assess a child with ear pain or, in younger children, irritability, crying, ear pulling and disturbed sleep. Fever, reduced feeding, vomiting, diarrhoea and malaise can accompany the local symptoms. [1]
- Diagnosis is primarily clinical with careful otoscopy. Pneumatic otoscopy is preferred to assess tympanic-membrane movement and confirm middle-ear effusion; tympanometry can provide supporting evidence. Routine laboratory testing is unnecessary in uncomplicated cases. [1]
- A bulging tympanic membrane is the most reliable clinical sign. Distinguish acute infection from otitis media with effusion, in which non-purulent fluid and a retracted membrane occur without acute inflammatory signs. [1]
Relieve pain and decide on immediate antibiotics
- Give adequate analgesia regardless of whether antibiotics are prescribed. Acetaminophen or ibuprofen are the principal analgesic options listed in the chapter. [1]
- The age table recommends immediate antibiotics for all cases under 6 months. Severe symptoms in the older age groups also warrant immediate treatment: moderate or severe pain, pain lasting more than 48 hours, or temperature at least 39°C. [1]
- For ages 6–23 months, non-severe bilateral disease requires immediate antibiotics, whereas non-severe unilateral disease allows antibiotics or observation after a joint decision with parents. [1]
- From 24 months, non-severe unilateral or bilateral disease can be managed with antibiotics or observation by shared decision with parents. Observation requires reliable review; start antibiotics if symptoms worsen or do not improve within 48–72 hours. [1]
Choose an appropriate antibiotic
- Amoxicillin is IAP’s first-line treatment at 40–45 mg/kg/day divided into 2–3 doses. The source notes that double this dose is often used where pneumococcal penicillin resistance is prevalent; use local resistance context rather than treating the higher dose as universal. [1]
- Prefer amoxicillin–clavulanate after recent amoxicillin exposure, with concurrent purulent conjunctivitis, or when beta-lactamase-producing organisms are suspected. [1]
- For non-type-I penicillin hypersensitivity, oral cefdinir, cefpodoxime or cefuroxime may be used. Reserve macrolides or clindamycin for severe beta-lactam allergy. [1]
- The chapter’s general duration section lists 10 days for children under 2 years and 5–7 days for those over 2 when using amoxicillin, amoxicillin–clavulanate, oral cephalosporins, clarithromycin or clindamycin. It lists 5 days for azithromycin and one to three ceftriaxone doses according to response. [1]
Reassess failure and recurrent disease
- Reassess lack of improvement within 48–72 hours. The treatment-failure table advises switching to amoxicillin–clavulanate; persistent failure prompts tympanocentesis and culture to guide treatment. [1]
- Recurrent disease is defined as three episodes in 6 months or four within 1 year. Consider tympanostomy tubes to reduce recurrence and repeated antibiotic exposure, and arrange ENT input where appropriate. [1]
- Do not use routine prophylactic antibiotics for recurrent disease because sustained benefit is limited and antimicrobial resistance is a concern. [1]
Monitor vulnerable children and reduce recurrence risk
- Infants under 6 months, immunocompromised children and children with craniofacial anomalies need prompt antibiotics and close monitoring. Watch for hearing impairment when middle-ear effusion persists, especially during speech and language development. [1]
- Intracranial complications, including meningitis, brain abscess, subdural empyema and venous sinus thrombosis, require urgent management. Prevention includes immunization, exclusive breastfeeding and avoiding tobacco-smoke exposure. [1]
Limitations and use
- The chapter reproduces age-selection and treatment-failure tables labelled as AAP guidance within the IAP document. Its duration categories use younger than two and older than two years, leaving exactly two years unspecified; no boundary is inferred here. Detailed dosing ceilings and individual prescribing contraindications are not established for every option. The treatment-failure table lists a three-day clindamycin schedule, differing from the general duration section; rescue dosing and duration require review of the complete source and individual prescribing assessment.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Acute Otitis Media
Selected recommendation material consulted
Publication details
- Issuing organisation
- IAP
- Resource type
- Practice guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.